[The CD133 polyclonal antibody generation and cancer stem cells identification]

Jun-Long Tian1, Pei-Ling Cai, Xiao-Qiang Xia

  • 1State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.

Summary

Researchers developed a highly effective CD133 polyclonal antibody for cancer stem cell (CSC) research. This antibody accurately identifies CSCs in glioblastoma tissues and aids in CSC screening for mouse models.